Rapport Therapeutics target price raised to $82 from $50
RAPP•JonesTrading raised its target price for Rapport Therapeutics to $82 from $50.
Related News
Trinity Capital Inc: Clear Street raises target price to $19 from $18
TRIN•
INmune Bio targets UK Ebstrocel approval in mid-2027
INMB•
Gladstone Investment target price raised to $17 from $15
GAIN•
Samsung Electro-Mechanics, NVIDIA invest in ABF substrate capacity expansion in South Korea
NVDA•
Vertiv and NVIDIA team up to accelerate AI factory deployment
VRT•